OPEN END TURBO BULL OPTIONSSCHEIN - IPSEN | Market Closed - Deutsche Boerse AG 13:35:36 2024-05-29 EDT | ||
| 1.99 EUR | +3.11% |
|
| Current month | +29.22% | ||
| 1 month | +45.26% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
Latest news about IPSEN
More news
| Date | Price | Change |
|---|---|---|
| 24-05-29 | 1.99 | +3.11% |
| 24-05-28 | 1.93 | -9.81% |
| 24-05-27 | 2.14 | -6.55% |
| 24-05-24 | 2.29 | -1.72% |
| 24-05-23 | 2.33 | +5.43% |
Delayed Quote Deutsche Boerse AG
Last update May 29, 2024 at 01:35 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | 
UniCredit
|
| WKN | HC2MMM |
| ISIN | DE000HC2MMM9 |
| Date issued | 2022-12-16 |
| Strike | 101.2 € |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.02 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.65 € |
|---|---|
| Lowest since issue | 0.47 € |
| Spread | 0.32 € |
| Spread % | 14.35% |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
120
EUR
Average target price
126.4
EUR
Spread / Average Target
+5.33%
- Stock Market
- Certificates
- Certificat
